The skinny on Martin Shkreli, the acquirer of Turing Pharmaceuticals. Raise a couple of hundred million. Buy orphan drug. (Drugs with less than 3000 patients) Insurance companies +FDA won’t pay for or certify the viability of cheaper foreign generics/biosimilars. Make Insurance companies foot the bill. If the patient doesn’t have insurance, give it away for […]
Kumar Thangudu